thromboxanes has been researched along with Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Li, J; Liu, M; Ren, Y; Ruan, Y; Zheng, Z | 1 |
| Murias, M; Piotrowska, H; Prukała, W; Regulska, K; Regulski, M; Stanisz, B | 1 |
| Lane, K; Marshall, K; Senior, J | 1 |
| Eskafi, S; Nigam, S; Roscher, A; Zakrzewicz, A | 1 |
| Herman, AG; Keersmaeckers, GH; Laekeman, GM; Uyttenbroeck, FL; van Dam, PA; Vergote, IB | 1 |
| Aitokallio-Tallberg, A; Kärkkäinen, J; Pantzar, P; Wahlström, T; Ylikorkala, O | 1 |
| Becquart, D; Buytaert, P; Heiremans, J; Herman, A; Laekeman, G; Vergote, I | 1 |
| Barbero, M; Becker, R; Benedetto, C; Hammerstein, J; Nigam, S; Rosendahl, U; Slater, TF | 1 |
| Baccarini, G; Barbero, M; Benedetto, C; Ghiringhello, B; Massobrio, M; Petitti, E; Rey, L; Slater, TF | 1 |
2 review(s) available for thromboxanes and Breast Neoplasms
| Article | Year |
|---|---|
COX-2 inhibitors: a novel strategy in the management of breast cancer.
Topics: Animals; Breast Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Prostaglandins; Quantitative Structure-Activity Relationship; Thromboxanes | 2016 |
Clinical significance of prostacyclin and thromboxane in cancer of the female breast and genital tract.
Topics: Breast Neoplasms; Epoprostenol; Female; Genital Neoplasms, Female; Humans; Thromboxanes | 1992 |
7 other study(ies) available for thromboxanes and Breast Neoplasms
| Article | Year |
|---|---|
Relationship between the n-3 index, serum metabolites and breast cancer risk.
Topics: Adult; Alprostadil; Biomarkers; Breast Neoplasms; Case-Control Studies; China; Fatty Acids; Fatty Acids, Omega-3; Female; Humans; Metabolomics; Middle Aged; Risk Factors; Thromboxanes | 2021 |
Growth inhibitory effects of thromboxane antagonists on breast cancer cell lines: a preliminary study.
Topics: Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Humans; Hydrazines; Phenylacetates; Prostaglandins, Synthetic; Sulfonamides; Thromboxanes; Tumor Cells, Cultured | 1997 |
Prostacyclin/thromboxane ratio in human breast cancer.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Epoprostenol; Humans; Middle Aged; Prognosis; Prospective Studies; Radioimmunoassay; Thromboxanes | 1991 |
Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antineoplastic Agents; Breast Diseases; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Epoprostenol; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Steroid; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer.
Topics: Breast Neoplasms; Dinoprost; Epoprostenol; Female; Humans; Prostaglandins F; Thromboxanes | 1986 |
The concentrations of 6-keto-PGF1 alpha and TXB2 in plasma samples from patients with benign and malignant tumours of the breast.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Thromboxane B2; Thromboxanes | 1985 |
Production of prostacyclin (PGI2) and thromboxane A2 (TXA2) by vessels draining and not-draining benign and malignant tumours of the breast.
Topics: Adult; Aged; Breast Neoplasms; Epoprostenol; Female; Humans; Middle Aged; Radioimmunoassay; Thromboxane A2; Thromboxanes; Veins | 1985 |